The CTSMA offers its members FREE online continuing educational programs. If you are not a member of the CTSMA, do not worry, anyone can take the continuing educational programs provided by the CTSMA.  For out-of-state AAMA members, there is a fee of $5 for each program. For non-AAMA members, there is a fee of $10 for each continuing educational program. If you are interested in becoming a member of the CTSMA to take advantage of the FREE online CEU Programs for our members, click on the "Join Now" button on the bottom of the page.

Every six months we offer three different programs. The programs require you to watch a presentation or read an article, then complete a test at the end. You must score 70% or above to receive credit for completing the continuing educational program. Once you have completed the program, there are a few different ways of submitting your test:

         1. E-mail-  you completed test to CEUPrograms@ctsma.org 

         2. Mail a copy of your test to Jennifer Amaral, CMA(AAMA), 208 Deerfield Ridge Drive, Mystic CT 06355

CEUs will be submitted to the AAMA at the end of the CEU Program. Please allow 6-8 weeks after the posted closing date of the program for credits to show on your AAMA transcript.

Any questions regarding the online continuing educational programs, please e-mail them to CEUprograms@ctsma.org

 
    

Metastatic Prostate Cancer: Current Trends and Future Landscape
1.0  AAMA CEU Credit

   

Improving Recognition and Prevention of Residual Paralysis After Surgery: Case Examples of Monitoring and Reversal

1.0 AAMA CEU CREDIT

  

SPRING/SUMMER CTSMA CEU PROGRAMS

Test Must Be Submitted By September 30, 2017

 

AAMA National E-Learning Center

The AAMA Continuing Education Board is committed to enhancing the professional education they offer you and is diligently working on new and fresh content. The AAMA offers an E-Learning Center to help CMA(AAMA) receive continuing educational credit for renewal of their certification. Click on the links below to be directed to the AAMA E-Learning Center.

 

Online Continuing Education

The goal of this activity is to educate health care professionals about improving patient outcomes in metastatic prostate cancer.

Learning Objectives

*Communicate with patients and colleagues about the pathophysiology, risk factors, symptoms, and genetics of prostate cancer.

*Create individualized treatment plans for patients with prostate cancer based on current screening and staging guidelines and evidence for monotherapy, combination therapy, and sequencing of therapies.

*Evaluate data for the benefits and risks of current and evolving strategies in the treatment of metastatic prostate cancer.

Neuromuscular blocking agents (NMBAs) cause generalized paralysis of skeletal muscles and prevent involuntary movement during surgical procedures. Often, residual paralysis remains postoperatively—a phenomenon known as residual neuromuscular blockade (RNMB)—and is associated with both short- and long-term morbidity. Despite the risks associated with RNMB, methods to reduce its occurrence through monitoring and reversal are not applied universally in clinical practice.

Educational Objectives

Recognize the prevalence and degree of morbidity and adverse events associated with RNMB in patients who have undergone general anesthesia for a surgical procedure.

Advocate for the consistent use of quantitative monitoring for RNMB.
Describe the appropriate use of NMBA reversal agents based on their mechanisms of action.
Faculty

 
 

Add Text Here...